# ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

Study · id `cardio:ct-nct04503395` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04503395](<https://clinicaltrials.gov/study/NCT04503395>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04503395

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 204 participants.

## Technical summary

Registry record NCT04503395. Randomized; no masking; primary purpose treatment. Start 2021-05-21 (actual); primary completion 2026-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 204 participants (planned count; ClinicalTrials.gov record NCT04503395, source copy `cardio:ctgov-nct04503395-2026-05-22`, retrieved 2026-11-18)
- Started: 2021-05-21 (actual) (ClinicalTrials.gov record NCT04503395, source copy `cardio:ctgov-nct04503395-2026-05-22`, retrieved 2026-11-18)
- Primary completion: 2026-06-01 (anticipated) (ClinicalTrials.gov record NCT04503395, source copy `cardio:ctgov-nct04503395-2026-05-22`, retrieved 2026-11-18)
- Completion: 2032-06-01 (anticipated) (ClinicalTrials.gov record NCT04503395, source copy `cardio:ctgov-nct04503395-2026-05-22`, retrieved 2026-11-18)
- Countries: United States; Austria; Belgium; France; Germany; Italy; Netherlands; Poland; Spain; Switzerland (ClinicalTrials.gov record NCT04503395, source copy `cardio:ctgov-nct04503395-2026-05-22`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04503395-2026-05-22`, retrieved 2026-11-18)

## The registry's words

- Brief title: ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- Acronym: SOCRATES
- Condition: Aortic Aneurysm, Abdominal
- Intervention (Device): ESAR treatment: Endograft + Heli-FX Endoanchor
- Intervention (Device): FEVAR treatment : Fenestrated endograft
- Lead sponsor: FCRE (Foundation for Cardiovascular Research and Education)
- Lead sponsor class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

## Provenance

Content hash: f9d33c9f025a75ff76be2a0b2238b0de6dce327f3e627811d6956fe11a220dbf
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
